I would have thought they would release the announcement about the FDA meetings prior to the presentation on the 05/06/2018. Don't they have an obligation to us share holders if it is considered price sensitive prior to announcing at a public presentation???
We know on 15th May they said next announcement would be within 30 days, so unless the next announcement relating to the FDA meeting is considered none price sensitive they would need to formally advise share holders prior to the presentation on the 5th June 2018.
Just my thoughts, but am I wrong?
Baldy
Ann: Recce Pharmaceuticals to Present at Investor Conference, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $118.1M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 46.5¢ | $2.131K | 4.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1263 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 11173 | 5 |
View Market Depth
| Last trade - 12.38pm 04/12/2024 (20 minute delay) ? |
| RCE (ASX) Chart |
